Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.

Interventional oncology 360 Pub Date : 2016-11-01 Epub Date: 2016-11-17
Dong-Hyun Kim, Andrew C Larson
{"title":"Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.","authors":"Dong-Hyun Kim,&nbsp;Andrew C Larson","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The efficacy of conventional transarterial chemoembolization (TACE) approaches in liver cancer treatment is limited by the lack of effective drug carriers and/or the inability to monitor drug delivery to the targeted tumor tissues. Recent years have seen rapid advances in drug carriers for TACE. Bioabsorbable and MRI- or CT-visible microspheres that are trackable in vivo have been developed as a form of nanocomposite. Herein, we review notable progress in nanocomposite microspheres drug carriers available for TACE.</p>","PeriodicalId":92226,"journal":{"name":"Interventional oncology 360","volume":"4 11","pages":"E173-E182"},"PeriodicalIF":0.0000,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889143/pdf/nihms873042.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional oncology 360","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/11/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The efficacy of conventional transarterial chemoembolization (TACE) approaches in liver cancer treatment is limited by the lack of effective drug carriers and/or the inability to monitor drug delivery to the targeted tumor tissues. Recent years have seen rapid advances in drug carriers for TACE. Bioabsorbable and MRI- or CT-visible microspheres that are trackable in vivo have been developed as a form of nanocomposite. Herein, we review notable progress in nanocomposite microspheres drug carriers available for TACE.

Abstract Image

纳米复合载体在肝癌动脉化疗栓塞中的应用。
传统的经动脉化疗栓塞(TACE)方法在肝癌治疗中的疗效受到缺乏有效药物载体和/或无法监测药物递送到靶向肿瘤组织的限制。近年来,TACE药物载体的研究进展迅速。生物可吸收和MRI或ct可见的微球,在体内可追踪已经发展成为纳米复合材料的一种形式。在此,我们综述了可用于TACE的纳米复合微球药物载体的显著进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信